UK markets closed
NIKKEI 225
38,179.46 -49.65 (-0.13%) HANG SENG
19,115.06 +151.38 (+0.80%) CRUDE OIL
79.19 +0.93 (+1.19%) GOLD FUTURES
2,344.00 -31.00 (-1.31%) DOW
39,431.51 -81.33 (-0.21%) Bitcoin GBP
50,272.21 +1,393.95 (+2.85%)
BMY Sep 2024 30.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:24PM EDT. Market open.
| Previous close | 14.87 |
| Open | 15.35 |
| Bid | 15.15 |
| Ask | 15.35 |
| Strike | 30.00 |
| Expiry date | 2024-09-20 |
| Day's range | 14.87 - 15.35 |
| Contract range | N/A |
| Volume | |
| Open interest | 23 |
Yahoo FinanceOne stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
Barrons.comThese Stocks Are Moving the Most Today: GameStop, AMC, Arm, Squarespace, Walgreens, Tesla, Intel, Apple, and More
GameStop shares continue their surge in May, a report says Arm Holdings seeks to launch its first artificial-intelligence chips next year, and Squarespace is being taken private in a deal valued at $6.9 billion.
ZacksBristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Bristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails to meet the primary endpoint of progression-free survival in unresectable stage III NSCLC.
© 2024 Yahoo. All rights reserved.